Overview

Zestra in Women With Mixed Sexual Dysfunction

Status:
Completed
Trial end date:
2007-03-01
Target enrollment:
Participant gender:
Summary
The objective of this study is to evaluate the clinical efficacy and safety of Zestra(TM) in women with acquired mixed desire/interest/arousal/orgasm disorders under conditions of home usage. The primary efficacy hypothesis will compare the effect of Zestra versus placebo on the incidence of "successful and satisfactory" sexual encounters.
Phase:
Phase 3
Details
Lead Sponsor:
QualiLife Pharmaceuticals